These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22749796)

  • 1. Vaccine production training to develop the workforce of foreign institutions supported by the BARDA influenza vaccine capacity building program.
    Tarbet EB; Dorward JT; Day CW; Rashid KA
    Vaccine; 2013 Mar; 31(12):1646-9. PubMed ID: 22749796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive hands-on training for influenza vaccine manufacturing: a WHO-BARDA-BTEC partnership for global workforce development.
    Ruiz J; Gilleskie GL; Brown P; Burnett B; Carbonell RG
    Biochem Mol Biol Educ; 2014; 42(5):414-9. PubMed ID: 25132407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers.
    Wahid R; Holt R; Hjorth R; Berlanda Scorza F
    Vaccine; 2016 Oct; 34(45):5430-5435. PubMed ID: 27484011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international technology platform for influenza vaccines.
    Hendriks J; Holleman M; de Boer O; de Jong P; Luytjes W
    Vaccine; 2011 Jul; 29 Suppl 1():A8-11. PubMed ID: 21684431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pandemic influenza vaccine production capacity in Viet Nam.
    Hoa LK; Hiep LV; Be LV
    Vaccine; 2011 Jul; 29 Suppl 1():A34-6. PubMed ID: 21684426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.
    Friede M; Palkonyay L; Alfonso C; Pervikov Y; Torelli G; Wood D; Kieny MP
    Vaccine; 2011 Jul; 29 Suppl 1():A2-7. PubMed ID: 21684422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: addressing the threat of an influenza pandemic.
    Surichan S; Wirachwong P; Supachaturas W; Utid K; Theerasurakarn S; Langsanam P; Lakornrach P; Nitisaporn L; Chansikkakorn C; Vangkanonta W; Kaweepornpoj R; Poopipatpol K; Thirapakpoomanunt S; Srichainak S; Artavatkun W; Chokevivat V; Wibulpolprasert S
    Vaccine; 2011 Jul; 29 Suppl 1():A29-33. PubMed ID: 21684425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania.
    Fox CB; Huynh C; O'Hara MK; Onu A
    Vaccine; 2013 Mar; 31(12):1633-40. PubMed ID: 23103197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of pandemic influenza vaccine production capacity at Bio Farma, Indonesia.
    Suhardono M; Ugiyadi D; Nurnaeni I; Emelia I
    Vaccine; 2011 Jul; 29 Suppl 1():A22-5. PubMed ID: 21684423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia.
    Ventura R; Brunner L; Heriyanto B; de Boer O; O'Hara M; Huynh C; Suhardono M; Collin N
    Vaccine; 2013 Mar; 31(12):1641-5. PubMed ID: 22884665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO influenza vaccine technology transfer initiative: role and activities of the Technical Advisory Group.
    Francis DP; Grohmann G
    Vaccine; 2011 Jul; 29 Suppl 1():A45-7. PubMed ID: 21684429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influenza vaccine: globalization of public health stakes].
    Collin N; Briand S
    Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pandemic influenza vaccine in India: from strain to sale within 12 months.
    Dhere R; Yeolekar L; Kulkarni P; Menon R; Vaidya V; Ganguly M; Tyagi P; Barde P; Jadhav S
    Vaccine; 2011 Jul; 29 Suppl 1():A16-21. PubMed ID: 21684421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domestic influenza vaccine production in Mexico: a state-owned and a multinational company working together for public health.
    Ponce-de-Leon S; Velazquez-Fernandez R; Bugarin-González J; García-Bañuelos P; Lopez-Sotelo A; Jimenez-Corona ME; Padilla-Catalan F; Cervantes-Rosales R
    Vaccine; 2011 Jul; 29 Suppl 1():A26-8. PubMed ID: 21684424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations for sustainable influenza vaccine production in developing countries.
    Nannei C; Chadwick C; Fatima H; Goldin S; Grubo M; Ganim A
    Vaccine; 2016 Oct; 34(45):5425-5429. PubMed ID: 27614783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global production capacity of seasonal influenza vaccine in 2011.
    Partridge J; Kieny MP
    Vaccine; 2013 Jan; 31(5):728-31. PubMed ID: 23149268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casting off vaccine supply charity -- the pace quickens. CVI goal: quality vaccines for all children.
    CVI Forum; 1995 Oct; (10):9-13. PubMed ID: 12290725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.